Treatment of Hepatitis C with ledipasvir, sofosbuvir with or without ribavirin in post liver transplant patients in an academic center

被引:0
|
作者
Pyrsopoulos, Nikolaos [1 ]
Lingiah, Vivek A. [1 ]
Sanaka, Sirish [1 ]
Fung, Phoenix [1 ]
Punnoose, Merlin [1 ]
机构
[1] Univ Hosp, Liver Transplant, Newark, NJ USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1636
引用
收藏
页码:810A / 810A
页数:1
相关论文
共 50 条
  • [21] Retrospective Cohort Study: Ledipasvir-Sofosbuvir With/Without Ribavirin for Chronic Hepatitis C Post-Liver Transplant in a Real-World Population
    Hawkins, Kelsey L.
    Hot, Ives
    [J]. JOURNAL OF PHARMACY TECHNOLOGY, 2018, 34 (05) : 199 - 203
  • [22] Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir/Sofosbuvir Plus Ribavirin Pretransplant
    Vinaixa, Carmen
    Berenguer, Marina
    [J]. ANNALS OF HEPATOLOGY, 2017, 16 (03) : 322 - 323
  • [23] Ledipasvir and Sofosbuvir plus /- Ribavirin in Post-hepatic Transplant Patients Reinfected with Genotype 1 Hepatitis C at University Hospitals Case Medical Center
    Zachariah, Robin
    Venkat, Deepak
    Muneer, Badar
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S859 - S860
  • [24] Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir I Sofosbuvir Plus Ribavirin Pretransplant
    Yoshida, Eric M.
    Kwo, Paul
    Agarwal, Kosh
    Duvoux, Christophe
    Durand, Francois
    Peck-Radosavljevic, Markus
    Lilly, Leslie
    Willems, Bernard
    Vargas, Hugo
    Kumar, Princy
    Brown, Robert S., Jr.
    Horsmans, Yves
    De-Oertel, Shampa
    Arterburn, Sarah
    Dvory-Sobol, Hadas
    Brainard, Diana M.
    McHutchison, John G.
    Terrault, Norah
    Rizzetto, Mario
    Muellhaupt, Beat
    [J]. ANNALS OF HEPATOLOGY, 2017, 16 (03) : 375 - 381
  • [25] Sofosbuvir plus ledipasvir for recurrent hepatitis C in liver transplant recipients
    Altraif, Ibrahim Hamad
    [J]. LIVER TRANSPLANTATION, 2017, 23 (04) : 554 - 556
  • [26] Ledipasvir-sofosbuvir and sofosbuvir plus ribavirin in patients with chronic hepatitis C and bleeding disorders
    Walsh, C. E.
    Workowski, K.
    Terrault, N. A.
    Sax, P. E.
    Cohen, A.
    Bowlus, C. L.
    Kim, A. Y.
    Hyland, R. H.
    Han, B.
    Wang, J.
    Stamm, L. M.
    Brainard, D. M.
    McHutchison, J. G.
    von Drygalski, A.
    Rhame, F.
    Fried, M. W.
    Kouides, P.
    Balba, G.
    Reddy, K. R.
    [J]. HAEMOPHILIA, 2017, 23 (02) : 198 - 206
  • [27] Outcome of Hepatitis C Treatment in Patients with Decompensated Cirrhosis Treated with Ledipasivir/Sofosbuvir with and without Ribavirin or Sofosbuvir with Ribavirin: Real Life Data. Retrospective Transplant Center Experience
    Selim, Khaled
    Long, Wen
    Elhazin, Bridgeida
    Salazar, Jennifer
    Karmanova, Marina
    Volk, Michael
    [J]. TRANSPLANTATION, 2016, 100 : S254 - S255
  • [28] Treatment of Patients with Hepatitis C Virus infection (Genotype 4) with Ledipasvir-Sofosbuvir in the liver transplant setting
    Abaalkhail, Faisal A.
    Elsiesy, Hussein A.
    Al Sebayel, Mohammed
    Aljedai, Ahmed
    Ajlan, Aziza A.
    Elbeshbeshy, Hany
    Al-Hamoudi, Waleed K.
    [J]. HEPATOLOGY, 2016, 64 : 956A - 957A
  • [29] Ledipasvir/sofosbuvir with or without ribavirin for the treatment of chronic hepatitis C genotype 1: A pairwise meta-analysis
    Ferreira, Vinicius L.
    Assis Jarek, Nayara A.
    Tonin, Fernanda S.
    Borba, Helena H. L.
    Wiens, Astrid
    Muzzillo, Dominique A.
    Pontarolo, Roberto
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 (04) : 749 - 755
  • [30] Sofosbuvir/ledipasvir and ribavirin tolerability and efficacy in pediatric liver transplant recipients
    Huysentruyt, Koen
    Stephenne, Xavier
    Varma, Sharat
    Scheers, Isabelle
    Leclercq, Gisele
    Smets, Francoise
    Sokal, Etienne M.
    [J]. LIVER TRANSPLANTATION, 2017, 23 (04) : 552 - 553